These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 32534953)

  • 1. CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.
    Das A; Weigle AT; Arnold WR; Kim JS; Carnevale LN; Huff HC
    Pharmacol Ther; 2020 Nov; 215():107601. PubMed ID: 32534953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2J2 - regulation, function and polymorphism.
    Murray M
    Drug Metab Rev; 2016 Aug; 48(3):351-68. PubMed ID: 27286171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte-specific CYP2J2 and its therapeutic implications.
    Valencia R; Bassiouni W; Darwesh AM; Bapuji R; Seubert JM
    Expert Opin Drug Metab Toxicol; 2022; 18(7-8):423-439. PubMed ID: 35997132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
    PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
    Chen C; Wang DW
    Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
    Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase.
    Carnevale LN; Arango AS; Arnold WR; Tajkhorshid E; Das A
    Biochemistry; 2018 Nov; 57(46):6489-6499. PubMed ID: 30285425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.
    Arnold WR; Baylon JL; Tajkhorshid E; Das A
    Biochemistry; 2016 Dec; 55(50):6969-6980. PubMed ID: 27992998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells.
    Jiang JG; Shen GF; Chen C; Fu XN; Wang DW
    Ai Zheng; 2009 Jan; 28(1):14-9. PubMed ID: 19448409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
    Nakayama K; Nitto T; Inoue T; Node K
    Life Sci; 2008 Aug; 83(9-10):339-45. PubMed ID: 18675280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.
    Chen G; Wang P; Zhao G; Xu G; Gruzdev A; Zeldin DC; Wang DW
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):63-71. PubMed ID: 21742052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
    Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.
    Lee CR; Imig JD; Edin ML; Foley J; DeGraff LM; Bradbury JA; Graves JP; Lih FB; Clark J; Myers P; Perrow AL; Lepp AN; Kannon MA; Ronnekleiv OK; Alkayed NJ; Falck JR; Tomer KB; Zeldin DC
    FASEB J; 2010 Oct; 24(10):3770-81. PubMed ID: 20495177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications.
    Sisignano M; Steinhilber D; Parnham MJ; Geisslinger G
    Drug Discov Today; 2020 Sep; 25(9):1744-1753. PubMed ID: 32652311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent expression of cytochrome p450 epoxygenases during human prenatal development.
    Cizkova K; Konieczna A; Erdosova B; Ehrmann J
    Organogenesis; 2014 Jan; 10(1):53-61. PubMed ID: 24492490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450-derived eicosanoids and heart function.
    Jamieson KL; Endo T; Darwesh AM; Samokhvalov V; Seubert JM
    Pharmacol Ther; 2017 Nov; 179():47-83. PubMed ID: 28551025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
    Nayeem MA; Geldenhuys WJ; Hanif A
    Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.